Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Keros Therapeutics Inc. logo

Keros Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

64.66
 
USD
  
-1.45
  
(-2.19%)
Optionable: No  Market Cap: 2,379 M  90-day average vol: 454,362

Previous close: 66.11  Open: 59.2  Bid: 62.29  Ask: 67.26
52 week range    
27.02   
   73.00
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 28th March 2024
56
MarketXLS Rank
55
Value
69
Technical
44
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

KROS Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22
AccruedPreferredStockDividends45 M59 M105 M
Basic EPS from continuing operations-2.93-2.52-4.15
Basic EPS total-2.93-2.52-4.15
Basic weighted shares outstanding16 M23 M25 M
Depreciation300000.0400000.0700000.0
DepreciationAndAmortization300000.0400000.0700000.0
Diluted EPS total-2.93-2.52-4.15
Diluted normalized net income/share-2.52-4.15
Diluted weighted shares outstanding16 M23 M25 M
GeneralAndAdministrativeExpense13 M21 M28 M
Gross operating profit20 M
Income before tax-46 M-57 M-105 M
Income taxes-172000.02 M
Interest income-6000.0
InterestExpenseNonOperating6000.04000.01000.0
MiscOtherSpecialCharges3 M-356000.010 M
Net income from total operations-45 M-59 M-105 M
NetIncomeCommonStockholders-45 M-59 M-105 M
NetIncomeContinuousOperations-45 M-59 M-105 M
NetNonOperatingInterestIncomeExpense-6000.0-4000.0-1000.0
Normalized income-45 M-83 M
Operating income-47 M-56 M-115 M
Operating income before depreciation (EBITDA)-45 M-56 M-103 M
OperatingExpense47 M76 M115 M
Other income net-1 M356000.0-10 M
OtherGandA13 M21 M28 M
OtherOperatingExpenses468000.0600000.01 M
OtherunderPreferredStockDividend45 M59 M105 M
PreferredStockDividends45 M59 M105 M
Research & development expense34 M55 M87 M
ResearchExpense34 M55 M87 M
Selling Gen & administrative expense13 M21 M28 M
Total Income available for interest expense (EBIT)-46 M-57 M-105 M
Total common shares outstanding23 M29 M
Total net income-45 M-59 M-105 M
Total ordinary shares36 M36 M36 M
Total revenues20 M
TotalExpenses47 M76 M115 M
TotalRevenue20 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University